CASPeR Ranking #54
Nippon India Nifty Pharma ETF
NAV (Tue Jan 14 2025)
₹23
Returns (Since Inception)
17.35%
Category Average
18.34%
Rating
NA
Allocation and Holdings
Asset class
Weightage
Healthcare
80.11%
Get your personalized mutual fund portfolio in 2 minutes.
4.5Overall rating
Scheme Information
Fund name
Nippon India Nifty Pharma ETF
Minimum SIP
1000
Risk Level
Very High Risk
AUM
₹922.81 Cr
ISIN
INF204KC1089
Inception Date
Jul 06 2021
Standard Deviation
16.28
Beta
1
Sharpe Ratio
0.767
Benchmark
IISL Nifty Pharma TR INR
Expense Ratio
0.210%
Exit Load
Risk
Very High Risk
Investment Objective
The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.
Fund Managers
Mehul Dama
About the AMC
Nippon Life India Asset Management Ltd
Phone Number
022-6808 7000/18602660111Email Address
customercare@nipponindiaim.inCorporate Office Address
Nippon Life India Asset Management Limited,4th Floor, Tower A, Peninsula Business Park,,Ganapatrao Kadam Marg,,Lower Parel (W)Overall AUM
₹922.81 Cr
Popular Hybrid Funds
View all funds
Popular Equity funds
View all Funds
Franklin India Equity Advantage Fund Direct Growth
₹3491.35 Cr
11.36%
SBI PSU Regular Growth
₹4572.13 Cr
29.49%
Nippon India ELSS Tax Saver Fund Direct Plan - Growth Option
₹15198.77 Cr
14.12%
Nippon India Multi Cap Fund - Direct Plan - Growth
₹39385.20 Cr
22.30%
Quant Focused fund Growth Option Direct Plan
₹1075.42 Cr
15.21%
Expert designed mutual fund portfolios
Mutual Funds are a smart way to grow your money. They can help you achieve your financial goals as they have the potential to generate higher-than-inflation returns.
subscribe to The Sunday Investor & impress
your coworkers with your finance insights
no promotions • no spam • only finance
